Molina Healthcare (MOH) Competitors

Humana (NYSE:HUM) and Molina Healthcare (NYSE:MOH) are both large-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, valuation, risk, institutional ownership, media sentiment, earnings, community ranking, analyst recommendations and dividends.

Is HUM or MOH more profitable?

Molina Healthcare has a net margin of 2.90% compared to Humana's net margin of 1.02%. Molina Healthcare's return on equity of 28.13% beat Humana's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Humana	1.02%	11.70%	3.99%
Molina Healthcare	2.90%	28.13%	8.43%

Which has more risk & volatility, HUM or MOH?

Humana has a beta of 0.62, meaning that its stock price is 38% less volatile than the S&P 500. Comparatively, Molina Healthcare has a beta of 0.7, meaning that its stock price is 30% less volatile than the S&P 500.

Do institutionals and insiders hold more shares of HUM or MOH?

92.4% of Humana shares are owned by institutional investors. Comparatively, 98.5% of Molina Healthcare shares are owned by institutional investors. 0.4% of Humana shares are owned by company insiders. Comparatively, 1.1% of Molina Healthcare shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Does the MarketBeat Community favor HUM or MOH?

Humana received 349 more outperform votes than Molina Healthcare when rated by MarketBeat users. Likewise, 62.59% of users gave Humana an outperform vote while only 56.92% of users gave Molina Healthcare an outperform vote.

Company	Underperform	Outperform
Humana	Outperform Votes 900 62.59%	Underperform Votes 538 37.41%
Molina Healthcare	Outperform Votes 551 56.92%	Underperform Votes 417 43.08%

Which has higher valuation and earnings, HUM or MOH?

Humana has higher revenue and earnings than Molina Healthcare. Molina Healthcare is trading at a lower price-to-earnings ratio than Humana, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Humana	$117.76B	0.26	$1.21B	$9.95	25.95
Molina Healthcare	$41.87B	0.41	$1.18B	$20.71	15.36

Does the media favor HUM or MOH?

In the previous week, Humana had 34 more articles in the media than Molina Healthcare. MarketBeat recorded 61 mentions for Humana and 27 mentions for Molina Healthcare. Molina Healthcare's average media sentiment score of 1.25 beat Humana's score of 0.96 indicating that Molina Healthcare is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Humana	28 Very Positive mention(s)	7 Positive mention(s)	14 Neutral mention(s)	5 Negative mention(s)	0 Very Negative mention(s)	Positive
Molina Healthcare	17 Very Positive mention(s)	3 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Do analysts rate HUM or MOH?

Humana presently has a consensus target price of $287.76, indicating a potential upside of 11.44%. Molina Healthcare has a consensus target price of $365.38, indicating a potential upside of 14.89%. Given Molina Healthcare's stronger consensus rating and higher possible upside, analysts plainly believe Molina Healthcare is more favorable than Humana.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Humana	0 Sell rating(s)	17 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.29
Molina Healthcare	0 Sell rating(s)	9 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.40

Summary

Molina Healthcare beats Humana on 11 of the 18 factors compared between the two stocks.